Therapeutic activity of NK cells against tumors

Area of Science:

• Immunology
• Cancer Biology
• Cell Therapy

Background:

• Natural killer (NK) cells are crucial for innate immunity, offering a first line of defense against circulating tumor cells and preventing metastasis.
• Despite their role in eliminating circulating tumor cells, the therapeutic efficacy of NK cells against established solid tumors remains a significant challenge in oncology.

Purpose of the Study:

• To review current research aimed at improving the therapeutic effectiveness of activated natural killer (NK) cells.
• To identify and understand the biological challenges that limit the clinical success of NK cell-based cancer therapies.

Main Methods:

• Comprehensive literature review of preclinical studies in animal models.
• Analysis of data from clinical trials investigating NK cell therapies.
• Examination of biological mechanisms underlying NK cell function and limitations.

Main Results:

• Various strategies are being explored to enhance NK cell activity, including cytokine activation, genetic modification, and combination therapies.
• Key biological barriers to NK cell effectiveness include the tumor microenvironment, immune evasion by cancer cells, and suboptimal NK cell persistence or function.
• Preclinical and clinical data highlight the potential of optimized NK cell approaches but underscore the need for further research.

Conclusions:

• Enhancing the therapeutic potential of NK cells requires overcoming specific biological hurdles within the tumor microenvironment.
• Further research and clinical investigation are essential to fully harness the power of NK cell immunotherapy for cancer treatment.